It is a federal list of certain active pharmaceutical ingredients that may be used in traditional, patient-specific compounding when the other requirements of section 503A are met
Much of the modern enthusiasm for GHK-Cu traces to a body of gene-expression work suggesting the peptide can influence the activity of a very large number of human genes, with reviews describing modulation of thousands of gene sets involved in tissue remodeling, inflammation, and repair
Somigliana E, Sarais V, Reschini M, et al
biologically-oriented common variant burden profiling reflects polygenic modulation of key pathways such as inflammation, lipid metabolism, mitochondrial function and synaptic integrity
These mutations are in strong linkage disequilibrium, creating a two-allele risk haplotype and hence increasing the overall risk of this disease [14]